Drug Approvals
🌏 NMPA Page 3NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 25–36 of 97 articles
Hong Kong Overhauls Drug Approval Process: What Pharma BD Teams Need to Know
Dishman Carbogen Amcis Shanghai Site Achieves NMPA GMP Compliance with Zero Findings
UCB's Bimzelx Triumph: Psoriatic Arthritis Market Implications and Competitive Landscape
Rusan Pharma Secures PMDA GMP Approval, Boosting Global Market Access
Estado Actual y Acciones para Impulsar la Investigación Clínica en México: 2025
Merck's Phase 3 Program: Addressing the Gaps
GlycoNex Secures PMDA Approval for GNX1021 Phase I Trial
Disparities in Early Access to Innovative Therapies: A Global Overview
Pharmaceuticals Market Size and Share Analysis for 2034
Biomarkers and Digital Technologies Transforming Oncology in Asia
Innovative Oncology Pharma Companies in China: A Look Ahead
Asia Pacific eClinical Solutions Market Report 2025-2030: Key Insights